Search by Drug Name or NDC
NDC 58407-0625-01 STAHIST AD 25; 60 mg/1; mg/1 Details
STAHIST AD 25; 60 mg/1; mg/1
STAHIST AD is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Magna Pharmaceuticals, Inc.. The primary component is CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.
Product Information
| NDC | 58407-0625 |
|---|---|
| Product ID | 58407-625_07737712-83d6-fd68-e063-6294a90a4b5c |
| Associated GPIs | 43993002280320 |
| GCN Sequence Number | 068279 |
| GCN Sequence Number Description | chlorcyclizine/pseudoephedrine TABLET 25 MG-60MG ORAL |
| HIC3 | Z2N |
| HIC3 Description | 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION |
| GCN | 31036 |
| HICL Sequence Number | 037465 |
| HICL Sequence Number Description | CHLORCYCLIZINE HCL/PSEUDOEPHEDRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | STAHIST AD |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25; 60 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Labeler Name | Magna Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58407-0625-01 (58407062501)
| NDC Package Code | 58407-625-01 |
|---|---|
| Billing NDC | 58407062501 |
| Package | 1 TABLET in 1 BLISTER PACK (58407-625-01) |
| Marketing Start Date | 2019-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |